Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Atopic ocular disease.

Erich C Strauss1, C Stephen Foster

  • 1Division of Immunology Service, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA. strauss@itsa.ucsf.edu

Ophthalmology Clinics of North America
|June 18, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saliva as a noninvasive diagnostic for ocular sarcoidosis.

Journal of leukocyte biology·2026
Same author

Oral cyclophosphamide as part of the treatment regimen in patients with nonparaneoplastic autoimmune retinopathy secondary to birdshot chorioretinopathy.

Oman journal of ophthalmology·2026
Same author

How to interpret low-dose valacyclovir for postherpetic neuralgia in the Zoster Eye Disease Study-a randomized clinical trial.

Annals of translational medicine·2026
Same author

Oral cyclophosphamide monotherapy in advanced resistant ocular cicatricial pemphigoid.

Taiwan journal of ophthalmology·2025
Same author

The Rate of Failure of Trabeculectomy and Tube Shunt Surgery in Eyes with Uveitic Glaucoma and Ocular Hypertension.

Ophthalmology. Glaucoma·2025
Same author

Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis.

Ocular immunology and inflammation·2025
Same journal

Contrast sensitivity and measuring cataract outcomes.

Ophthalmology clinics of North America·2006
Same journal

Capsular tension rings: update on endocapsular support devices.

Ophthalmology clinics of North America·2006
Same journal

Management of vitreous loss and dropped nucleus during cataract surgery.

Ophthalmology clinics of North America·2006
Same journal

Astigmatism control.

Ophthalmology clinics of North America·2006
Same journal

New technology IOL optics.

Ophthalmology clinics of North America·2006
Same journal

Phaco fluidics and phaco ultrasound power modulations.

Ophthalmology clinics of North America·2006
See all related articles

Atopic ocular diseases involve allergic inflammation with varying severity. Understanding molecular mechanisms may lead to new preventative strategies beyond symptomatic relief for conditions like allergic conjunctivitis.

Area of Science:

  • Ophthalmology and immunology, focusing on allergic inflammatory responses in the eye.

Background:

  • Atopic ocular diseases encompass a range of immuno-inflammatory conditions.
  • Severity varies, from minimal changes in seasonal allergic conjunctivitis (SAC) to chronic inflammation in giant papillary conjunctivitis (GPC), vernal keratoconjunctivitis (VKC), and atopic keratoconjunctivitis (AKC).

Purpose of the Study:

  • To review the spectrum of atopic ocular diseases and their underlying immuno-inflammatory mechanisms.
  • To highlight the limitations of current symptomatic treatments and the potential for future preventative strategies.

Main Methods:

  • Review of existing literature on the pathophysiology of atopic ocular diseases.
  • Analysis of cellular and molecular mechanisms involved in allergic eye inflammation.

Main Results:

Related Experiment Videos

  • Seasonal allergic conjunctivitis (SAC) shows minimal pathology.
  • Perennial allergic conjunctivitis (PAC) involves mast cell activation and late-phase inflammation.
  • Chronic forms (GPC, VKC, AKC) exhibit persistent activation of mast cells, eosinophils, and lymphocytes, leading to significant pathological changes.

Conclusions:

  • Current therapies primarily address symptoms of atopic ocular diseases.
  • Deeper understanding of allergic inflammatory pathways opens avenues for developing novel preventative treatments.